Patents Represented by Attorney Iris Pharmaceuticals, Inc. Patent Dept.
  • Patent number: 7754698
    Abstract: Disclosed herein are compounds, compositions and methods for modulating the expression of FR-alpha in a cell, tissue or animal. Also provided are methods of target validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders.
    Type: Grant
    Filed: January 8, 2008
    Date of Patent: July 13, 2010
    Assignee: Isis Pharmaceuticals, Inc.
    Inventor: Susan M. Freier